Schedule 13D ownership disclosure

Spark Therapeutics, Inc.

Security class unavailable · CUSIP: 84652J103

Event date: 2015-01-29

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
8,937,415
Percent of class
36.4000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-15-007088
Form type
SC 13D
Filer
Children's Hospital of Philadelphia Foundation
CIK
CIK 1632060
Filed
Feb 05, 2015
Reporting period
Jan 29, 2015
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub